Don Rockey to Injections, Subcutaneous
This is a "connection" page, showing publications Don Rockey has written about Injections, Subcutaneous.
Connection Strength
0.039
-
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology. 2018 10; 155(4):1140-1153.
Score: 0.039